Shenzhen Salubris Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Shenzhen Salubris Pharmaceuticals has a total shareholder equity of CN¥8.6B and total debt of CN¥60.0M, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are CN¥10.2B and CN¥1.6B respectively. Shenzhen Salubris Pharmaceuticals's EBIT is CN¥594.0M making its interest coverage ratio -10. It has cash and short-term investments of CN¥1.9B.
Key information
0.7%
Debt to equity ratio
CN¥60.00m
Debt
| Interest coverage ratio | -10x |
| Cash | CN¥1.91b |
| Equity | CN¥8.64b |
| Total liabilities | CN¥1.59b |
| Total assets | CN¥10.23b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002294's short term assets (CN¥3.8B) exceed its short term liabilities (CN¥1.0B).
Long Term Liabilities: 002294's short term assets (CN¥3.8B) exceed its long term liabilities (CN¥576.9M).
Debt to Equity History and Analysis
Debt Level: 002294 has more cash than its total debt.
Reducing Debt: 002294's debt to equity ratio has reduced from 5.4% to 0.7% over the past 5 years.
Debt Coverage: 002294's debt is well covered by operating cash flow (1930.7%).
Interest Coverage: 002294 earns more interest than it pays, so coverage of interest payments is not a concern.